The primary etiological factor of chronic myeloid leukemia (CML) is the BCR::ABL1 fusion protein, which is a highly active tyrosine kinase capable of initiating multiple downstream oncogenic pathways1,2. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.